elevated lipase semaglutide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Safety and tolerability of semaglutide

Vomiting: 20-21%

AWARD-7 enrolled adult patients with T2D (A1c, 7.5%10.5%) and CKD stages 34 who were being treated with ACEi or ARBs and found that dulaglutide (0.75 or 1.5 mg subcutaneous once weekly) achieved similar glycemic control to insulin glargine but had significantly less eGFR decline (mean 0.7 vs 3.3 mL/min/1.73 m 2 , respectively

If you would like to learn more about GLP-1 medications or want to see if you might be eligible for medication-assisted weight loss, check out Mochi Health, where board-certified obesity medicine physicians can offer expertise in this realm

To defend your weight loss after stoppingor while on maintenance therapyanchor three behavioral pillars: protein intake (1.0 to 1.2 grams per kilogram of body weight daily) to preserve muscle and satiety, structured strength training 2 to 3 times weekly to offset metabolic decline, and consistent sleep (7 to 9 hours nightly) to regulate hunger hormones and cortisol

Pabreja, K